Literature DB >> 12112000

High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells.

Ulrike Benbow1, Grant B Tower, Colby A Wyatt, Giovanna Buttice, Constance E Brinckerhoff.   

Abstract

Matrix metalloproteinase-1 (MMP-1) is one of only a few enzymes with the ability to degrade the stromal collagens (types I and III) at neutral pH, and high expression of MMP-1 has been associated with aggressive and invasive cancers. We recently reported a single nucleotide insertion/deletion polymorphism (SNP) in the collagenase-1 (MMP-1) promoter (Rutter et al. [1998] Can. Res. 58:5321-5325), where the insertion of an extra guanine (G) at -1607 bp creates the sequence, 5'-GGAA-3 (2G allele), compared to the sequence 5'-GAA-3' (1G allele). The presence of 2G constitutes a binding site for the ETS family of transcription factors, and increases MMP-1 transcription in fibroblasts and A2058 melanoma cells cultured in vitro. In addition, the presence of the 2G allele has been linked to several aggressive malignancies as well as to enhanced expression of MMP-1. In this study, we describe a melanoma cell line, VMM5, that is 1G homozygous, but that is invasive and expresses high levels of MMP-1 constitutively. The high level of MMP-1 expression in VMM5 cells is due to the utilization of both the p38 and ERK1/2 transduction pathways. In contrast, in the A2058 cell line, which also expresses MMP-1 constitutively and which is 2G homozygous, only the ERK pathway is activated. Thus, our data suggest that in the absence of 2G allele and in the presence of the appropriate transcription factors, tumor cells may use alternative signal/transduction pathways and cis-acting sequences to achieve high levels of MMP-1 expression, which contribute to the ability of tumor cells to invade, regardless of their genotype. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112000     DOI: 10.1002/jcb.10225

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells.

Authors:  Gaurav Kaushik; Satish Ramalingam; Dharmalingam Subramaniam; Parthasarthy Rangarajan; Piero Protti; Prabhu Rammamoorthy; Shrikant Anant; Joshua M V Mammen
Journal:  Am J Surg       Date:  2012-12       Impact factor: 2.565

2.  MMP-2 (-1306 C/T) Polymorphism Affects Serum Matrix Metalloproteinase (MMP)-2 Levels and Correlates with Chronic Obstructive Pulmonary Disease Severity: A Case-Control Study of MMP-1 and -2 in a Tunisian Population.

Authors:  Sarra Bchir; Hela Ben Nasr; Amel Ben Anes; Mohamed Benzarti; Abdelhamid Garrouch; Zouhair Tabka; Karim Chahed
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

3.  Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.

Authors:  Hongliang Liu; Qingyi Wei; Jeffrey E Gershenwald; Victor G Prieto; Jeffrey E Lee; Madeleine Duvic; Elizabeth A Grimm; Li-E Wang
Journal:  Melanoma Res       Date:  2012-04       Impact factor: 3.599

4.  Matrix metalloproteinase-1 promoter -1607 bp 1G/2G polymorphism associated with increased risk of spinal tuberculosis in Southern Chinese Han population.

Authors:  Ying Zhou; Qile Gao; Dan He; Ang Deng; Rongfu Huang; Yanbing Li; Chunyan Tan; Chaofeng Guo; Qiang Guo; Longjie Wang; Guanteng Yang; Hongqi Zhang
Journal:  J Clin Lab Anal       Date:  2017-01-27       Impact factor: 2.352

5.  The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression.

Authors:  Eric Guenzi; Kristin Töpolt; Clara Lubeseder-Martellato; Anita Jörg; Elisabeth Naschberger; Roberto Benelli; Adriana Albini; Michael Stürzl
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

6.  Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter.

Authors:  Becky A Mercer; Alison M Wallace; Constance E Brinckerhoff; Jeanine M D'Armiento
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-10       Impact factor: 6.914

7.  Molecular bases of cutaneous and uveal melanomas.

Authors:  Sudeep Gaudi; Jane L Messina
Journal:  Patholog Res Int       Date:  2011-08-18

8.  Matrix metalloproteinase-1 (MMP-1) Promoter polymorphisms are well linked with lower stomach tumor formation in eastern Indian population.

Authors:  Sanjib Dey; Nillu Ghosh; Debjit Saha; Kousik Kesh; Arnab Gupta; Snehasikta Swarnakar
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

9.  Matrix metalloproteinase-1 polymorphism (-1607G) and disease severity in non-cystic fibrosis bronchiectasis in Taiwan.

Authors:  Meng-Heng Hsieh; Pai-Chien Chou; Chun-Liang Chou; Shu-Chuan Ho; Wen-Ching Joa; Li-Fei Chen; Te-Fang Sheng; Horng-Chyuan Lin; Tsai-Yu Wang; Po-Jui Chang; Chun-Hua Wang; Han-Pin Kuo
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

10.  Association between promoter -1607 polymorphism of MMP1 and lumbar disc disease in Southern Chinese.

Authors:  You-Qiang Song; Daniel W H Ho; Jaro Karppinen; Patrick Y P Kao; Bao-Jian Fan; Keith D K Luk; Shea-Ping Yip; John C Y Leong; Kathryn S E Cheah; Pak Sham; Danny Chan; Kenneth M C Cheung
Journal:  BMC Med Genet       Date:  2008-04-28       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.